相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Congenital diaphragmatic hernia-associated pulmonary hypertension
Vikas S. Gupta et al.
SEMINARS IN PERINATOLOGY (2020)
Early postnatal changes of circulating N-terminal-pro-B-type natriuretic peptide in neonates with congenital diaphragmatic hernia
Katrin Heindel et al.
EARLY HUMAN DEVELOPMENT (2020)
Ventricular Dysfunction Is a Critical Determinant of Mortality in Congenital Diaphragmatic Hernia
Neil Patel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children
Vivianne Amiet et al.
PEDIATRIC CARDIOLOGY (2018)
The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension
John P. Kinsella et al.
JOURNAL OF PEDIATRICS (2018)
Echocardiographic Evaluation of Ventricular Function-For the Neonatologist and Pediatric Intensivist.
Cecile Tissot et al.
FRONTIERS IN PEDIATRICS (2018)
Early Postnatal Ventricular Dysfunction Is Associated with Disease Severity in Patients with Congenital Diaphragmatic Hernia
Neil Patel et al.
JOURNAL OF PEDIATRICS (2018)
Levosimendan in pulmonary hypertension and right heart failure
Mona Sahlholdt Hansen et al.
PULMONARY CIRCULATION (2018)
Congenital diaphragmatic hernia-associated pulmonary hypertension
Matthew T. Harting
SEMINARS IN PEDIATRIC SURGERY (2017)
High-Sensitivity Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Prediction of Outcome in Congenital Diaphragmatic Hernia: Results from a Multicenter, Randomized Controlled Trial
Kitty G. Snoek et al.
JOURNAL OF PEDIATRICS (2016)
Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus-2015 Update
Kitty G. Snoek et al.
NEONATOLOGY (2016)
Persistence of Pulmonary Hypertension by Echocardiography Predicts Short-Term Outcomes in Congenital Diaphragmatic Hernia
Leslie A. Lusk et al.
JOURNAL OF PEDIATRICS (2015)
The Inotropic Effect of the Active Metabolite of Levosimendan, OR-1896, Is Mediated through Inhibition of PDE3 in Rat Ventricular Myocardium
Oivind Orstavik et al.
PLOS ONE (2015)
Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery
Abdelhay A. Ebade et al.
JOURNAL OF ANESTHESIA (2013)
Levosimendan in Two Neonates with Ischemic Heart Failure and Pulmonary Hypertension
Maria Pia De Carolis et al.
NEONATOLOGY (2012)
Use of Milrinone to Treat Cardiac Dysfunction in Infants with Pulmonary Hypertension Secondary to Congenital Diaphragmatic Hernia: A Review of Six Patients
Neil Patel
NEONATOLOGY (2012)
Targeted Neonatal Echocardiography in the Neonatal Intensive Care Unit: Practice Guidelines and Recommendations for Training
Luc Mertens et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2011)
Congenital Diaphragmatic Hernia Endothelin-1, Pulmonary Hypertension, and Disease Severity
Roberta L. Keller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass
Michael G. Gaies et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Repetitive Dosing of Intravenous Levosimendan Improves Pulmonary Hemodynamics in Patients With Pulmonary Hypertension: Results of a Pilot Study
Franz X. Kleber et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine
Yuksel Cavusoglu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
The calcium sensitizer levosimendan and cardiac arrhythmias:: an analysis of the safety database of heart failure treatment studies
J Lilleberg et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2004)
Levosimendan - A review of its use in the management of acute decompensated heart failure
CA Innes et al.
DRUGS (2003)
Myocardial efficiency during levosimendan infusion in congestive heart failure
H Ukkonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)